Shareholder stand

shaRehoLDeRs are expected to rebel against Takeda’s £46bn takeover of Londonlisted drug maker shire in a pivotal vote today.

But the revolt is only expected to muster support from investors holding around 20pc of the Japanese company – short of the 33pc needed to stop the deal. efforts to block the takeover have been led by Kazuhisa Takeda, a former director and a member of the group’s founding family, who has been speaking for some shareholders and former employees.

he said this week: ‘The financial risk is too big, while the expected merit is quite limited.’